Today's Earnings Calculators Terms of Service Privacy Policy Data Sources Support Mobile app Instagram

StockRay is an AI stock analysis service by Warm Tech Company.

Warm Tech Company | CEO Jinyoung Moon | Reg. 317-27-02126

13, Cheonggyesan-ro 4-gil, Sujeong-gu, Seongnam-si, Gyeonggi-do, Korea | partner@warmtech.company

All information provided by Warm Tech Company is for reference only and does not constitute a recommendation to buy or sell any specific stock. You are solely responsible for your investment decisions.

© 2026 Warm Tech Company. All rights reserved.

Natera, Inc. Stock Price·Forecast · AI Analysis | StockRay

Natera, Inc.

NTRA · Healthcare · $58.5B

After-hours $408.470.00%

2026 Q2 earnings

Price

$283.8

$408.5

Jul 6, 26Oct 1, 26

What's this stock's score right now?

See its score for free — revenue and money flow, graded on one standard.

Quarterly Financials

RevenueOperating IncomeNet Income

9/'26

Revenue$707M-6.1%

6/'26 vs prev quarter

Company Health

Market Cap$58.5B

Operating Margin-10.7%

Cash on Hand$1.1B1.9% of market cap

Free Cash Flow$72M0.1% of market cap

Among 39 Medical - Diagnostics & Research peers

LowMedianHigh

PSR21.6x

median 5.4xPBR32.1x

median 2.9xROE-10.6%

median -3.0%

New Publication Establishes Strong Clinical Validation of Signatera™ for MRD Assessment in LymphomaSep 1

Caisse de depot et placement du Quebec Buys New Shares in Natera, Inc. $NTRAAug 31

Billionaire Stanley Druckenmiller Has Roughly 17% of His $5.2 Billion Duquesne Portfolio in Natera Stock. Is It Still a Buy After an 80% Run?Aug 29

Natera & Angiex Partner to Evaluate AGX101 Response With SignateraAug 28

Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast CancerAug 28

Natera and Angiex Partner to Assess Response to Investigational Nuclear-Delivered Antibody-Drug Conjugate™ Using Signatera™Aug 27

Related Stocks

M
Moderna, Inc.
C
Cigna Corporation
B
Boston Scientific Corporation
C
Cencora, Inc.
a
argenx SE
T
Takeda Pharmaceutical Company Limited
C
Cardinal Health, Inc.
B
Becton, Dickinson and Company

Daily Prices

09.29$414.52-1.17%

09.28$411.77-0.19%

09.25$412.56+0.92%

09.24$408.79+4.61%

09.23$390.79-0.03%

09.22$390.90+5.47%

09.21$370.64+0.34%

09.18$369.39+0.84%

09.17$366.31+6.07%

09.16$345.34-1.55%

Quarterly Revenue Growth

PriorCurrent

25년 9월25년 12월26년 3월26년 6월26년 9월Est.

Revenue Breakdown

As of Dec 2025

Source: Company IR filings

Product99.6%
Licensing and other0.4%

BusinessMedical - Diagnostics & Research·natera.com↗

“이번 분기 매출 753억 달러로 전년 대비 38% 성장했는데, 직전 분기 697억 달러에서 이어진 가속 흐름이에요.”

In the company's words · 2026 2분기 earnings call